News


6 Lessons I Learned from Attending PODD and the MidAtlantic Capital Conference
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

As the co-founder of Calla Lily Clinical Care, I’m always on the lookout for the latest trends and insights shaping healthcare. And also opportunities to escape my children. Did I mention I have 3 pre-teen/teenagers? Recently, I had the opportunity to attend two distinctly different conferences: PODD (Partnership Opportunities in Drug Delivery) in Boston and …

Haley Clawsie Joins as Business Development & Research Intern

Excited to welcome Haley Clawsie to our team as our new Business Development & Research Intern. Currently pursuing her BBA in Finance and Business Law at Loyola Marymount University, Haley is temporarily swapping sunny Los Angeles ☀ for a new adventure (with slight change of scenery) in London. With a strong passion for purpose-driven innovation, …

Cell culture lab progress
Elham Shirani, PhD
Biomedical Engineer

I am proud that I have helped set up a fully operational cell culture lab dedicated to advancing research in the vaginal microbiome at Calla Lily Clinical Care! This accomplishment wouldn’t have been possible without the incredible support of my colleagues— Dr Serena de Gelidi, Stuart Prince, Ewa Radziwon, Dr Arturo Jose Mendoza Meinhardt, Kaylie …

Funded MSc + PhD Studentship: Delivery of live biotherapeutics for restoration of women’s reproductive health

Calla Lily Clinical Care is delighted to partner with the University of Warwick for this fully funded (incl student stipend) four-year iCASE studentship from September 2025, available as part of Warwick’s MRC-funded Doctoral Training Partnership (DTP). Vaginal microbiota play a key role in women’s reproductive health. Disruption of the normal vaginal microbiome is associated with inflammation …

Presenting at the Mid-Atlantic Capital Conference in Philadelphia
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

Today, I had the privilege of presenting Calla Lily Clinical Care’s latest innovation, Callavid®, at the MidAtlantic Capital Conference with PACT in Philadelphia. It’s an exciting step forward in women’s health, particularly for those navigating the challenges of IVF and miscarriage. Our Callavid technology harnesses the power of intravaginal drug delivery initially through our medical …

Precious Kilimo joins as MBA Strategy Intern
Thang Vo-Ta
Co-Founder & CEO

A warm welcome from myself, Lara, and the entire Calla Lily Clinical Care Team to Precious Kilimo, who joins us as an MBA Intern from London Business School where she is a Mo Ibrahim Foundation Scholar. 🏛 Prior to business school, Precious was instrumental in scaling Maisha Meds, a Kenyan health tech non-profit from a $300k …

A Look at Three Common Medications That Can Be Delivered Intravaginally
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

When one thinks about yeast infections, menopause and fertility support, the conversation usually revolves around pills or injections. But there’s a better, more targeted way to achieve results. The era of blanket treatments is fading. I used to joke that medicine isn’t Burger King–you can’t just have it your way. Except, that’s exactly what is …

Professor Andy Lewis presents at PODD 2024 in Boston

We had a great 2 days at the Partnerships in Drug Delivery PODD Conference in Boston with team members Professor Andrew Lewis and Dr Lara Zibners representing Calla Lily.   Besides Andy’s well received presentation on our Callavid vaginal drug delivery platform, there were also superb connections made with the wider drug delivery technology community, and …

Why Intravaginal Drug Delivery Is the Future of Women’s Health
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

When we talk about advancements in healthcare, the vagina doesn’t often make it into the conversation. But it should. Hell, it’s standard dinner conversation at my house. The power of the vagina as a vessel for targeted, effective treatment is an emerging trend in women’s health. A trend geared toward smarter, safer, more effective medication …

Pitching at the Merck Innovation Challenge
Thang Vo-Ta
Co-Founder & CEO

What a privilege it was for Lara and I to present Calla Lily Clinical Care to senior members of Merck Group and M Ventures . Selected out of 100+ women’s health startups from around the world, we were able to share our vision for our transformational Callavid drug delivery platform, beginning with pregnancy & fertility. …

We use cookies to enhance your website experience. We use necessary cookies to ensure our website functions properly and to keep it secure. These always need to be on. By clicking “Accept cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. Please view our privacy policy for further details.